Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 43 of 100

Brainstorm Health: CVS Benefits Change, Grail IPO, What Amazon and Location Say About Health

By Sy Mukherjee

Brainstorm Health: U.S. Health Workers, FDA Liver Drug Guidance, Psychedelic Mushrooms

By Sy Mukherjee

Brainstorm Health: GSK Tesaro Deal, VR Medical Education, Bluebird Bio

By Sy Mukherjee

Brainstorm Health: Editas CRISPR Study, Blood Pressure Drug Recalls, Measles and Ebola Outbreaks

By Sy Mukherjee

Brainstorm Health: Obamacare Waivers, AI and Human Emotions, China’s Gene Editing Move

By Sy Mukherjee

Brainstorm Health: Gene Editing Defense, Keto Diet Sensor, Rituxan Biosimilar

By Sy Mukherjee

Brainstorm Health: Roche Jecure Deal, Amazon AWS and Amgen, Vertex CF Drug

By Sy Mukherjee

Brainstorm Health: Gene Edited Babies, Medical Device Overhaul, CVS Aetna Deal

By Sy Mukherjee

Brainstorm Health: Abortion Rates Plunge, Novartis Pear Therapeutics Collaboration, 3D Body Scanner

By Sy Mukherjee

Brainstorm Health: HIV Prevention Pill, Pfizer Price Hikes, Chickenpox Outbreak

By Sy Mukherjee

Brainstorm Health: Peanut Allergy Drug, Tesaro Stock and Sale, Health Care Investments

By Sy Mukherjee

Brainstorm Health: Suicide Rates, AstraZeneca Cancer Miss, Alphabet’s Glucose Lens Fail

By Sy Mukherjee

Brainstorm Health: Health Care Business Leaders, FDA E-Cigs Ban, Health Care on the Blockchain

By Sy Mukherjee

Brainstorm Health: Virta Health Diabetes Program, J&J Talc Suit, Precision Medicine

By Sy Mukherjee

Brainstorm Health: Alcohol Abuse Screening, Juul Sales, SVB Leerink Merger

By Sy Mukherjee